Skip to content

Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain

Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01091090
Enrollment
26
Registered
2010-03-23
Start date
2009-11-30
Completion date
2011-09-30
Last updated
2012-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Smoking cessation, Nicotine dependence, Chronic pain

Brief summary

Millions of individuals with chronic pain smoke and our preliminary research suggests that currently available strategies to help people quit smoking may not be effective for individuals with chronic pain. This is important in that smokers with chronic pain have worse pain-related health outcomes compared to nonsmokers with chronic pain. The primary aim of this research project is to develop a smoking cessation intervention for specific use in an outpatient clinical setting for smokers with chronic pain.

Interventions

Cognitive behavioral intervention for smoking cessation

BEHAVIORALControl

Treatment as usual

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Chronic pain * Age \> 18 years * Cigarette smoker \> 10 per day

Exclusion criteria

* Concurrent substance use disorder other than nicotine dependence * Concurrent major psychiatric disorder

Design outcomes

Primary

MeasureTime frameDescription
The key measurement to be used to assess the effect of the experimental intervention will be the status of cigarette smoking at 6-month follow-up.6 monthsThe smoking status will be determined by assessing the 7-day point prevalence use of cigarettes which is defined as the use of any cigarettes within the preceding 7 days of the follow-up date at 6-months.

Secondary

MeasureTime frame
A key secondary outcome measure will be self-report pain severity at 6-months following completion of the experimental intervention.6 month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026